Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study.

Autor: Jónsdóttir ÁH; University of Iceland, Reykjavi-k, Iceland., Sigurjónsdóttir HÁ Prof; University of Iceland, Iceland., Thorsteinsdottir S; University of Iceland., Einarsson Long T; University of Iceland, Iceland., Sverrisdóttir IS; University of IcelandLandspitali - The National University Hospital of Iceland, Reykjavik, Iceland., Eythorsson E; University of Iceland, Iceland., Oskarsson JT; University of Iceland, Reykjavik, Iceland., Pálsson R; Landspitali University Hospital, Reykjavik, Iceland., Indridason OS; University of Iceland, Iceland., Vidarsson B; Landspítali-The National University Hospital of Iceland, Iceland., Onundarson PT; Landspitali National University Hospital, Reykjavik, Iceland., Olafsson I; Landspitali University Hospital and University of Iceland Faculty of Medicine, Reykjavik, Iceland., Þorsteinsdóttir I; -The National University Hospital of Iceland, Reykjavik, Iceland, Reykjavik, Iceland., Agnarsson BA; University of Iceland, Iceland., Sigurdardottir M; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Jonsson A; Akureyri Hospital, Iceland., Hultcrantz ML; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Durie BGM; Cedars-Sinai Outpatient Cancer Center, Los Angeles, California, United States., Harding S; The Binding Site Ltd., Birmingham, United Kingdom., Landgren CO; Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States., Love TJ; Akureyri Hospital, Iceland., Kristinsson SY; University of Iceland, Reykjavik, Iceland., Rögnvaldsson S; University of Iceland, Reykjavík, Iceland.

Publikováno v: Blood [Blood] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.